TL;DR
This retrospective study compared propofol and sevoflurane anesthesia in 192 glioma surgery patients. Sevoflurane anesthesia resulted in shorter anesthesia and extubation times, faster recovery of consciousness and cognitive function, and fewer postoperative complications compared to propofol. The findings suggest sevoflurane may be a more suitable anesthetic for glioma surgery.
What Problem Does This Paper Address?
Gliomas are the most common primary malignant brain tumors, and surgical resection is the primary treatment. However, the surgical process, including anesthesia, can negatively impact brain tissue and patient recovery. Choosing the right anesthetic is crucial for optimizing patient outcomes, minimizing complications, and potentially improving long-term prognosis. While both propofol (a common intravenous anesthetic) and sevoflurane (a common inhalational anesthetic) are used in neurosurgery, their comparative effects on glioma patients, particularly regarding recovery and postoperative complications, warrant further investigation. This study aims to address this by comparing the clinical effects of these two anesthetic agents in patients undergoing glioma surgery.
Methods
This was a retrospective study involving 192 patients who underwent glioma surgery between January 2016 and January 2021. Patients were randomly divided into two groups: an observation group (n=96) receiving sevoflurane anesthesia and a control group (n=96) receiving propofol anesthesia. Both groups received standard induction agents (etomidate, sufentanil, rocuronium) and continuous remifentanil infusion. Anesthesia was maintained with either sevoflurane (target BIS 40-60) or propofol (titrated dose).
Key observation metrics included:
- Intraoperative conditions: Anesthesia time, intracranial operation time, operation time, intraoperative bleeding volume, fluid intake, and urine output.
- Anesthetic recovery: Time to orientation recovery, respiratory recovery, eye-opening, extubation, and leaving the operating room.
- Consciousness and cognitive function: Assessed using the Oxford Assessment of Anesthesia Severity (OAAS) score and the Mini-Mental State Examination (MMSE) score at various time points post-extubation.
- Postoperative complications: Incidence of specific complications such as restlessness, urinary tract infection, deep vein thrombosis, and hypertension.
Statistical analysis involved one-way ANOVA, independent sample t-tests, and chi-squared tests to compare the groups.
Datasets
The study utilized data from 192 patients who underwent glioma surgery at the authors' hospital between January 2016 and January 2021. No new datasets were introduced.
Key Insights and Ideas
- Faster Recovery with Sevoflurane: The study highlights that sevoflurane anesthesia leads to significantly quicker recovery of orientation and eye-opening compared to propofol. This suggests a potentially less disruptive effect on immediate post-anesthetic neurological function.
- Improved Cognitive Function: Patients under sevoflurane anesthesia demonstrated higher OAAS scores (indicating better consciousness) and MMSE scores (indicating better cognitive function) post-extubation. This is a critical finding, as preserving cognitive function is paramount for glioma patients.
- Reduced Postoperative Complications: A notable finding is the lower incidence of certain postoperative complications, specifically restlessness, urinary tract infection, deep vein thrombosis, and hypertension, in the sevoflurane group. This points to a potentially safer overall anesthetic profile for this patient population.
- Anesthetic Efficiency: Shorter anesthesia and extubation times observed with sevoflurane suggest a more efficient anesthetic management, which can be beneficial in reducing operating room time and patient exposure.
Key Results
- Intraoperative: Sevoflurane group had significantly shorter anesthesia time (332 ± 86 min vs. 385 ± 127 min, P=0.001) and postoperative extubation time (1.26 ± 1.31 h vs. 4.79 ± 2.87 h, P<0.001). Intraoperative bleeding was also lower in the sevoflurane group (808 ± 457 ml vs. 993 ± 785 ml, P=0.047). No significant differences were found in intracranial operation time, operation time, fluid intake, or urine volume.
- Anesthetic Recovery: Orientation recovery time (17.19 ± 5.25 min vs. 23.59 ± 3.62 min, P<0.001) and eye-opening time (9.47 ± 3.31 min vs. 14.55 ± 2.28 min, P<0.001) were significantly shorter in the sevoflurane group.
- Consciousness & Cognition: OAAS scores were significantly higher in the sevoflurane group at all measured time points (after extubation, before leaving OR, and 1 hour after extubation). MMSE scores 1 hour after extubation were also significantly higher (28.38 ± 5.53 vs. 26.23 ± 4.48, P=0.003).
- Postoperative Complications: The incidence of restlessness (26.0% vs. 48.9%, P=0.015), urinary tract infection (18.8% vs. 40.6%, P=0.004), and deep vein thrombosis (13.5% vs. 26.0%, P=0.001) was significantly lower in the sevoflurane group. High blood pressure was also less frequent (10.4% vs. 22.9%, P=0.001).
Limitations and Future Work
- Retrospective Design: The study's retrospective nature is a limitation, meaning it cannot establish causality definitively. Future prospective studies are needed to confirm these findings.
- Sample Size: While 192 patients is a reasonable number, larger, multi-center studies are suggested by the authors to increase statistical power and generalizability.
- Specific Complications: The study noted no significant differences in several other potential complications (e.g., intracranial hemorrhage, infection, cerebral hernia). Further research could explore if sevoflurane has any subtle benefits in these areas over longer follow-up periods.
- Long-term Prognosis: The authors acknowledge that the effect of these anesthetic schemes on the long-term prognosis of gliomas was not significantly different in their study, suggesting this remains an area for further investigation.
The authors propose carrying out multi-center research with more comprehensive analyses to draw more reliable conclusions and explore the long-term impact of anesthetic choices on glioma patient outcomes.
Summary updated